Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.

@article{Frew2006EfficacyAS,
  title={Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.},
  author={Anthony J. Frew and Richard James Powell and Christopher J. Corrigan and Stephen R. Durham},
  journal={The Journal of allergy and clinical immunology},
  year={2006},
  volume={117 2},
  pages={319-25}
}
BACKGROUND Specific immunotherapy is widely used to treat allergic rhinitis, but few large-scale clinical trials have been performed. OBJECTIVE We sought to assess the efficacy and safety of specific immunotherapy with 2 doses of Alutard grass pollen in patients with moderately severe seasonal allergic rhinitis inadequately controlled with standard drug… CONTINUE READING